Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of ASP-001 (Flunarizine ODT) vs Sibelium in Healthy Participants
NCT07445464Phase 1Completed
- Sponsor
- Aspartes, Inc.
- Start
- Apr 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of flunarizine in migraine (5 arms), sponsored by Aspartes, Inc. Primary endpoints: Relative Bioavailability at Day 5, Area Under the Curve from Time Zero to Infinity at Day 5 and 7 more. Started Apr 2026; status: completed.
02
Drugs
flunarizine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07445464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07445464.